nodes	percent_of_prediction	percent_of_DWPC	metapath
Gefitinib—IRAK1—rheumatoid arthritis	0.435	0.929	CbGaD
Gefitinib—ALB—rheumatoid arthritis	0.0336	0.0716	CbGaD
Gefitinib—ALB—Auranofin—rheumatoid arthritis	0.0321	0.106	CbGbCtD
Gefitinib—ABCG2—Leflunomide—rheumatoid arthritis	0.03	0.099	CbGbCtD
Gefitinib—ABCG2—Sulfasalazine—rheumatoid arthritis	0.0186	0.0612	CbGbCtD
Gefitinib—ABCG2—Hydrocortisone—rheumatoid arthritis	0.0149	0.0491	CbGbCtD
Gefitinib—ABCG2—Cyclosporine—rheumatoid arthritis	0.0141	0.0464	CbGbCtD
Gefitinib—CYP2C9—Leflunomide—rheumatoid arthritis	0.0112	0.0368	CbGbCtD
Gefitinib—CYP3A5—Sulfasalazine—rheumatoid arthritis	0.0103	0.0339	CbGbCtD
Gefitinib—ALB—Prednisone—rheumatoid arthritis	0.0102	0.0337	CbGbCtD
Gefitinib—ABCG2—Dexamethasone—rheumatoid arthritis	0.00926	0.0305	CbGbCtD
Gefitinib—ABCB1—Methylprednisolone—rheumatoid arthritis	0.00883	0.0291	CbGbCtD
Gefitinib—CYP1A1—Dexamethasone—rheumatoid arthritis	0.00855	0.0282	CbGbCtD
Gefitinib—CYP3A5—Hydrocortisone—rheumatoid arthritis	0.00825	0.0272	CbGbCtD
Gefitinib—CYP3A5—Cyclosporine—rheumatoid arthritis	0.00779	0.0257	CbGbCtD
Gefitinib—ABCG2—Methotrexate—rheumatoid arthritis	0.00744	0.0245	CbGbCtD
Gefitinib—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.00717	0.0237	CbGbCtD
Gefitinib—CYP2C19—Prednisone—rheumatoid arthritis	0.00663	0.0219	CbGbCtD
Gefitinib—CYP2C19—Cyclosporine—rheumatoid arthritis	0.00628	0.0207	CbGbCtD
Gefitinib—ABCB1—Betamethasone—rheumatoid arthritis	0.00574	0.0189	CbGbCtD
Gefitinib—ABCB1—Prednisolone—rheumatoid arthritis	0.00566	0.0187	CbGbCtD
Gefitinib—ABCB1—Hydrocortisone—rheumatoid arthritis	0.00537	0.0177	CbGbCtD
Gefitinib—ABCB1—Prednisone—rheumatoid arthritis	0.00535	0.0176	CbGbCtD
Gefitinib—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.00529	0.0174	CbGbCtD
Gefitinib—CYP2C9—Cyclosporine—rheumatoid arthritis	0.00522	0.0172	CbGbCtD
Gefitinib—CYP3A5—Dexamethasone—rheumatoid arthritis	0.00513	0.0169	CbGbCtD
Gefitinib—ALB—Methotrexate—rheumatoid arthritis	0.00513	0.0169	CbGbCtD
Gefitinib—ABCB1—Cyclosporine—rheumatoid arthritis	0.00507	0.0167	CbGbCtD
Gefitinib—CYP2D6—Cyclosporine—rheumatoid arthritis	0.00478	0.0158	CbGbCtD
Gefitinib—CYP2C19—Dexamethasone—rheumatoid arthritis	0.00414	0.0136	CbGbCtD
Gefitinib—CYP3A4—Triamcinolone—rheumatoid arthritis	0.00401	0.0132	CbGbCtD
Gefitinib—CYP2C9—Dexamethasone—rheumatoid arthritis	0.00344	0.0113	CbGbCtD
Gefitinib—CYP3A4—Betamethasone—rheumatoid arthritis	0.00344	0.0113	CbGbCtD
Gefitinib—CYP3A4—Prednisolone—rheumatoid arthritis	0.00339	0.0112	CbGbCtD
Gefitinib—ABCB1—Dexamethasone—rheumatoid arthritis	0.00334	0.011	CbGbCtD
Gefitinib—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.00322	0.0106	CbGbCtD
Gefitinib—CYP3A4—Prednisone—rheumatoid arthritis	0.0032	0.0106	CbGbCtD
Gefitinib—CYP2D6—Dexamethasone—rheumatoid arthritis	0.00315	0.0104	CbGbCtD
Gefitinib—CYP3A4—Cyclosporine—rheumatoid arthritis	0.00304	0.01	CbGbCtD
Gefitinib—ABCB1—Methotrexate—rheumatoid arthritis	0.00268	0.00885	CbGbCtD
Gefitinib—CYP3A4—Dexamethasone—rheumatoid arthritis	0.002	0.0066	CbGbCtD
Gefitinib—ORM1—saliva—rheumatoid arthritis	0.00167	0.0769	CbGeAlD
Gefitinib—ERBB3—exocrine gland—rheumatoid arthritis	0.00151	0.0693	CbGeAlD
Gefitinib—Afatinib—IRAK1—rheumatoid arthritis	0.00108	0.195	CrCbGaD
Gefitinib—Erlotinib—PIP4K2C—rheumatoid arthritis	0.001	0.181	CrCbGaD
Gefitinib—SBK1—tendon—rheumatoid arthritis	0.000892	0.041	CbGeAlD
Gefitinib—CSNK1E—parotid gland—rheumatoid arthritis	0.000814	0.0374	CbGeAlD
Gefitinib—IRAK4—parotid gland—rheumatoid arthritis	0.000802	0.0368	CbGeAlD
Gefitinib—CSNK1E—saliva-secreting gland—rheumatoid arthritis	0.00078	0.0358	CbGeAlD
Gefitinib—CHEK2—tendon—rheumatoid arthritis	0.000777	0.0357	CbGeAlD
Gefitinib—IRAK4—saliva-secreting gland—rheumatoid arthritis	0.000768	0.0353	CbGeAlD
Gefitinib—ERBB3—saliva-secreting gland—rheumatoid arthritis	0.000753	0.0346	CbGeAlD
Gefitinib—MKNK2—parotid gland—rheumatoid arthritis	0.000747	0.0343	CbGeAlD
Gefitinib—MKNK2—saliva-secreting gland—rheumatoid arthritis	0.000716	0.0329	CbGeAlD
Gefitinib—ERBB3—connective tissue—rheumatoid arthritis	0.000692	0.0318	CbGeAlD
Gefitinib—MKNK2—connective tissue—rheumatoid arthritis	0.000658	0.0302	CbGeAlD
Gefitinib—Bosutinib—PRKCQ—rheumatoid arthritis	0.000618	0.112	CrCbGaD
Gefitinib—Bosutinib—SYK—rheumatoid arthritis	0.000618	0.112	CrCbGaD
Gefitinib—Afatinib—BLK—rheumatoid arthritis	0.000581	0.105	CrCbGaD
Gefitinib—MAP2K5—parotid gland—rheumatoid arthritis	0.000543	0.0249	CbGeAlD
Gefitinib—MAP2K5—saliva-secreting gland—rheumatoid arthritis	0.00052	0.0239	CbGeAlD
Gefitinib—CSNK1E—digestive system—rheumatoid arthritis	0.000518	0.0238	CbGeAlD
Gefitinib—IRAK4—lymphoid tissue—rheumatoid arthritis	0.000516	0.0237	CbGeAlD
Gefitinib—ERBB3—lymphoid tissue—rheumatoid arthritis	0.000506	0.0232	CbGeAlD
Gefitinib—ERBB3—digestive system—rheumatoid arthritis	0.000499	0.0229	CbGeAlD
Gefitinib—CSNK1E—tendon—rheumatoid arthritis	0.000493	0.0226	CbGeAlD
Gefitinib—IRAK4—tendon—rheumatoid arthritis	0.000485	0.0223	CbGeAlD
Gefitinib—MKNK2—lymphoid tissue—rheumatoid arthritis	0.000481	0.0221	CbGeAlD
Gefitinib—MKNK2—digestive system—rheumatoid arthritis	0.000475	0.0218	CbGeAlD
Gefitinib—MKNK1—lymphoid tissue—rheumatoid arthritis	0.000475	0.0218	CbGeAlD
Gefitinib—MKNK1—digestive system—rheumatoid arthritis	0.000469	0.0215	CbGeAlD
Gefitinib—Bosutinib—IRAK1—rheumatoid arthritis	0.000468	0.0847	CrCbGaD
Gefitinib—MKNK2—tendon—rheumatoid arthritis	0.000452	0.0208	CbGeAlD
Gefitinib—IRAK1—tendon—rheumatoid arthritis	0.000452	0.0208	CbGeAlD
Gefitinib—Bosutinib—PTK2—rheumatoid arthritis	0.000398	0.072	CrCbGaD
Gefitinib—STK10—lymphoid tissue—rheumatoid arthritis	0.000391	0.018	CbGeAlD
Gefitinib—STK10—digestive system—rheumatoid arthritis	0.000386	0.0177	CbGeAlD
Gefitinib—STK10—tendon—rheumatoid arthritis	0.000368	0.0169	CbGeAlD
Gefitinib—MAP2K5—tendon—rheumatoid arthritis	0.000328	0.0151	CbGeAlD
Gefitinib—Vandetanib—BLK—rheumatoid arthritis	0.00027	0.0489	CrCbGaD
Gefitinib—ABCG2—parotid gland—rheumatoid arthritis	0.000264	0.0121	CbGeAlD
Gefitinib—Bosutinib—BLK—rheumatoid arthritis	0.000253	0.0458	CrCbGaD
Gefitinib—ABCG2—saliva-secreting gland—rheumatoid arthritis	0.000253	0.0116	CbGeAlD
Gefitinib—CYP1A1—parotid gland—rheumatoid arthritis	0.000251	0.0115	CbGeAlD
Gefitinib—CSNK1E—Danazol—Hydrocortisone—rheumatoid arthritis	0.0002	0.0888	CbGdCrCtD
Gefitinib—CYP2C19—digestive system—rheumatoid arthritis	0.000198	0.00908	CbGeAlD
Gefitinib—CSNK1E—Danazol—Prednisone—rheumatoid arthritis	0.000173	0.0765	CbGdCrCtD
Gefitinib—CYP1A1—digestive system—rheumatoid arthritis	0.000159	0.00732	CbGeAlD
Gefitinib—CYP3A5—digestive system—rheumatoid arthritis	0.000156	0.00716	CbGeAlD
Gefitinib—CYP2C9—digestive system—rheumatoid arthritis	0.000153	0.00704	CbGeAlD
Gefitinib—Vandetanib—VEGFA—rheumatoid arthritis	0.000144	0.026	CrCbGaD
Gefitinib—CSNK1E—Betamethasone—Hydrocortisone—rheumatoid arthritis	0.000128	0.0567	CbGdCrCtD
Gefitinib—CSNK1E—Dexamethasone—Hydrocortisone—rheumatoid arthritis	0.000128	0.0567	CbGdCrCtD
Gefitinib—CHEK2—Testosterone Propionate—Hydrocortisone—rheumatoid arthritis	0.000123	0.0547	CbGdCrCtD
Gefitinib—CSNK1E—Betamethasone—Methylprednisolone—rheumatoid arthritis	0.000121	0.0535	CbGdCrCtD
Gefitinib—CSNK1E—Dexamethasone—Methylprednisolone—rheumatoid arthritis	0.000121	0.0535	CbGdCrCtD
Gefitinib—CSNK1E—Betamethasone—Dexamethasone—rheumatoid arthritis	0.000119	0.0527	CbGdCrCtD
Gefitinib—CSNK1E—Dexamethasone—Betamethasone—rheumatoid arthritis	0.000119	0.0527	CbGdCrCtD
Gefitinib—CYP3A4—digestive system—rheumatoid arthritis	0.000117	0.00537	CbGeAlD
Gefitinib—CSNK1E—Betamethasone—Triamcinolone—rheumatoid arthritis	0.000116	0.0515	CbGdCrCtD
Gefitinib—CSNK1E—Dexamethasone—Triamcinolone—rheumatoid arthritis	0.000116	0.0515	CbGdCrCtD
Gefitinib—CYP2D6—digestive system—rheumatoid arthritis	0.000115	0.00528	CbGeAlD
Gefitinib—CSNK1E—Betamethasone—Prednisone—rheumatoid arthritis	0.00011	0.0488	CbGdCrCtD
Gefitinib—CSNK1E—Dexamethasone—Prednisone—rheumatoid arthritis	0.00011	0.0488	CbGdCrCtD
Gefitinib—CSNK1E—Betamethasone—Prednisolone—rheumatoid arthritis	0.000108	0.0477	CbGdCrCtD
Gefitinib—CSNK1E—Dexamethasone—Prednisolone—rheumatoid arthritis	0.000108	0.0477	CbGdCrCtD
Gefitinib—CHEK2—Danazol—Hydrocortisone—rheumatoid arthritis	0.000103	0.0455	CbGdCrCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—rheumatoid arthritis	9.7e-05	0.00102	CcSEcCtD
Gefitinib—Urticaria—Leflunomide—rheumatoid arthritis	9.63e-05	0.00101	CcSEcCtD
Gefitinib—Body temperature increased—Leflunomide—rheumatoid arthritis	9.59e-05	0.00101	CcSEcCtD
Gefitinib—Abdominal pain—Leflunomide—rheumatoid arthritis	9.59e-05	0.00101	CcSEcCtD
Gefitinib—Malnutrition—Methylprednisolone—rheumatoid arthritis	9.57e-05	0.00101	CcSEcCtD
Gefitinib—Dry mouth—Cyclosporine—rheumatoid arthritis	9.55e-05	0.001	CcSEcCtD
Gefitinib—Angioedema—Prednisolone—rheumatoid arthritis	9.53e-05	0.001	CcSEcCtD
Gefitinib—Toxic epidermal necrolysis—Methotrexate—rheumatoid arthritis	9.48e-05	0.000995	CcSEcCtD
Gefitinib—Hypersensitivity—Azathioprine—rheumatoid arthritis	9.46e-05	0.000993	CcSEcCtD
Gefitinib—Malaise—Prednisolone—rheumatoid arthritis	9.41e-05	0.000988	CcSEcCtD
Gefitinib—Eye disorder—Betamethasone—rheumatoid arthritis	9.35e-05	0.000981	CcSEcCtD
Gefitinib—Eye disorder—Dexamethasone—rheumatoid arthritis	9.35e-05	0.000981	CcSEcCtD
Gefitinib—Angioedema—Hydrocortisone—rheumatoid arthritis	9.31e-05	0.000978	CcSEcCtD
Gefitinib—Infection—Cyclosporine—rheumatoid arthritis	9.3e-05	0.000976	CcSEcCtD
Gefitinib—CHEK2—Norethindrone—Hydrocortisone—rheumatoid arthritis	9.25e-05	0.041	CbGdCrCtD
Gefitinib—Malaise—Hydrocortisone—rheumatoid arthritis	9.19e-05	0.000965	CcSEcCtD
Gefitinib—Nervous system disorder—Cyclosporine—rheumatoid arthritis	9.18e-05	0.000964	CcSEcCtD
Gefitinib—Thrombocytopenia—Cyclosporine—rheumatoid arthritis	9.16e-05	0.000962	CcSEcCtD
Gefitinib—Skin disorder—Cyclosporine—rheumatoid arthritis	9.09e-05	0.000954	CcSEcCtD
Gefitinib—Angiopathy—Betamethasone—rheumatoid arthritis	9.07e-05	0.000953	CcSEcCtD
Gefitinib—Angiopathy—Dexamethasone—rheumatoid arthritis	9.07e-05	0.000953	CcSEcCtD
Gefitinib—Arrhythmia—Dexamethasone—rheumatoid arthritis	8.94e-05	0.000938	CcSEcCtD
Gefitinib—Arrhythmia—Betamethasone—rheumatoid arthritis	8.94e-05	0.000938	CcSEcCtD
Gefitinib—Hypersensitivity—Leflunomide—rheumatoid arthritis	8.93e-05	0.000938	CcSEcCtD
Gefitinib—Anorexia—Cyclosporine—rheumatoid arthritis	8.92e-05	0.000937	CcSEcCtD
Gefitinib—Pancreatitis—Methotrexate—rheumatoid arthritis	8.92e-05	0.000936	CcSEcCtD
Gefitinib—Alopecia—Betamethasone—rheumatoid arthritis	8.84e-05	0.000928	CcSEcCtD
Gefitinib—Alopecia—Dexamethasone—rheumatoid arthritis	8.84e-05	0.000928	CcSEcCtD
Gefitinib—CHEK2—Danazol—Prednisone—rheumatoid arthritis	8.84e-05	0.0392	CbGdCrCtD
Gefitinib—Diarrhoea—Azathioprine—rheumatoid arthritis	8.79e-05	0.000922	CcSEcCtD
Gefitinib—Angioedema—Triamcinolone—rheumatoid arthritis	8.77e-05	0.000921	CcSEcCtD
Gefitinib—Haemoglobin—Prednisone—rheumatoid arthritis	8.75e-05	0.000919	CcSEcCtD
Gefitinib—Angioedema—Methylprednisolone—rheumatoid arthritis	8.75e-05	0.000919	CcSEcCtD
Gefitinib—Haemorrhage—Prednisone—rheumatoid arthritis	8.71e-05	0.000915	CcSEcCtD
Gefitinib—Asthenia—Leflunomide—rheumatoid arthritis	8.7e-05	0.000914	CcSEcCtD
Gefitinib—Malaise—Triamcinolone—rheumatoid arthritis	8.65e-05	0.000909	CcSEcCtD
Gefitinib—Malaise—Methylprednisolone—rheumatoid arthritis	8.63e-05	0.000907	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—rheumatoid arthritis	8.62e-05	0.000905	CcSEcCtD
Gefitinib—Pruritus—Leflunomide—rheumatoid arthritis	8.58e-05	0.000901	CcSEcCtD
Gefitinib—Shock—Prednisolone—rheumatoid arthritis	8.38e-05	0.00088	CcSEcCtD
Gefitinib—ABCB1—lymphoid tissue—rheumatoid arthritis	8.38e-05	0.00385	CbGeAlD
Gefitinib—Cough—Triamcinolone—rheumatoid arthritis	8.37e-05	0.000879	CcSEcCtD
Gefitinib—Dyspnoea—Cyclosporine—rheumatoid arthritis	8.34e-05	0.000876	CcSEcCtD
Gefitinib—Diarrhoea—Leflunomide—rheumatoid arthritis	8.3e-05	0.000871	CcSEcCtD
Gefitinib—ABCB1—digestive system—rheumatoid arthritis	8.27e-05	0.0038	CbGeAlD
Gefitinib—Infection—Hydrocortisone—rheumatoid arthritis	8.26e-05	0.000868	CcSEcCtD
Gefitinib—Shock—Hydrocortisone—rheumatoid arthritis	8.18e-05	0.000859	CcSEcCtD
Gefitinib—Vomiting—Azathioprine—rheumatoid arthritis	8.16e-05	0.000857	CcSEcCtD
Gefitinib—Nervous system disorder—Hydrocortisone—rheumatoid arthritis	8.16e-05	0.000856	CcSEcCtD
Gefitinib—Pneumonia—Methotrexate—rheumatoid arthritis	8.16e-05	0.000856	CcSEcCtD
Gefitinib—Eye disorder—Prednisone—rheumatoid arthritis	8.14e-05	0.000855	CcSEcCtD
Gefitinib—Decreased appetite—Cyclosporine—rheumatoid arthritis	8.14e-05	0.000854	CcSEcCtD
Gefitinib—Infestation NOS—Methotrexate—rheumatoid arthritis	8.11e-05	0.000851	CcSEcCtD
Gefitinib—Infestation—Methotrexate—rheumatoid arthritis	8.11e-05	0.000851	CcSEcCtD
Gefitinib—Rash—Azathioprine—rheumatoid arthritis	8.1e-05	0.00085	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—rheumatoid arthritis	8.1e-05	0.00085	CcSEcCtD
Gefitinib—Dermatitis—Azathioprine—rheumatoid arthritis	8.09e-05	0.000849	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Cyclosporine—rheumatoid arthritis	8.08e-05	0.000848	CcSEcCtD
Gefitinib—Skin disorder—Hydrocortisone—rheumatoid arthritis	8.08e-05	0.000848	CcSEcCtD
Gefitinib—Fatigue—Cyclosporine—rheumatoid arthritis	8.07e-05	0.000847	CcSEcCtD
Gefitinib—Stevens-Johnson syndrome—Methotrexate—rheumatoid arthritis	8.04e-05	0.000844	CcSEcCtD
Gefitinib—Pain—Cyclosporine—rheumatoid arthritis	8e-05	0.00084	CcSEcCtD
Gefitinib—Constipation—Cyclosporine—rheumatoid arthritis	8e-05	0.00084	CcSEcCtD
Gefitinib—Dry mouth—Triamcinolone—rheumatoid arthritis	7.99e-05	0.000839	CcSEcCtD
Gefitinib—Angioedema—Dexamethasone—rheumatoid arthritis	7.96e-05	0.000835	CcSEcCtD
Gefitinib—Angioedema—Betamethasone—rheumatoid arthritis	7.96e-05	0.000835	CcSEcCtD
Gefitinib—Anorexia—Hydrocortisone—rheumatoid arthritis	7.93e-05	0.000832	CcSEcCtD
Gefitinib—Stomatitis—Methotrexate—rheumatoid arthritis	7.9e-05	0.00083	CcSEcCtD
Gefitinib—Angiopathy—Prednisone—rheumatoid arthritis	7.9e-05	0.00083	CcSEcCtD
Gefitinib—Conjunctivitis—Methotrexate—rheumatoid arthritis	7.88e-05	0.000828	CcSEcCtD
Gefitinib—Malaise—Betamethasone—rheumatoid arthritis	7.85e-05	0.000824	CcSEcCtD
Gefitinib—Malaise—Dexamethasone—rheumatoid arthritis	7.85e-05	0.000824	CcSEcCtD
Gefitinib—Arrhythmia—Prednisone—rheumatoid arthritis	7.78e-05	0.000817	CcSEcCtD
Gefitinib—Infection—Triamcinolone—rheumatoid arthritis	7.78e-05	0.000817	CcSEcCtD
Gefitinib—Hypotension—Hydrocortisone—rheumatoid arthritis	7.77e-05	0.000816	CcSEcCtD
Gefitinib—Infection—Methylprednisolone—rheumatoid arthritis	7.76e-05	0.000815	CcSEcCtD
Gefitinib—Haematuria—Methotrexate—rheumatoid arthritis	7.73e-05	0.000812	CcSEcCtD
Gefitinib—Vomiting—Leflunomide—rheumatoid arthritis	7.71e-05	0.00081	CcSEcCtD
Gefitinib—Shock—Triamcinolone—rheumatoid arthritis	7.71e-05	0.000809	CcSEcCtD
Gefitinib—Alopecia—Prednisone—rheumatoid arthritis	7.7e-05	0.000808	CcSEcCtD
Gefitinib—Shock—Methylprednisolone—rheumatoid arthritis	7.69e-05	0.000807	CcSEcCtD
Gefitinib—Hepatobiliary disease—Methotrexate—rheumatoid arthritis	7.67e-05	0.000805	CcSEcCtD
Gefitinib—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	7.66e-05	0.000805	CcSEcCtD
Gefitinib—Gastrointestinal pain—Cyclosporine—rheumatoid arthritis	7.65e-05	0.000804	CcSEcCtD
Gefitinib—Epistaxis—Methotrexate—rheumatoid arthritis	7.65e-05	0.000803	CcSEcCtD
Gefitinib—Rash—Leflunomide—rheumatoid arthritis	7.65e-05	0.000803	CcSEcCtD
Gefitinib—Dermatitis—Leflunomide—rheumatoid arthritis	7.64e-05	0.000802	CcSEcCtD
Gefitinib—Nausea—Azathioprine—rheumatoid arthritis	7.63e-05	0.000801	CcSEcCtD
Gefitinib—Skin disorder—Methylprednisolone—rheumatoid arthritis	7.59e-05	0.000797	CcSEcCtD
Gefitinib—Malnutrition—Prednisone—rheumatoid arthritis	7.58e-05	0.000796	CcSEcCtD
Gefitinib—Urticaria—Cyclosporine—rheumatoid arthritis	7.43e-05	0.000781	CcSEcCtD
Gefitinib—Abdominal pain—Cyclosporine—rheumatoid arthritis	7.4e-05	0.000777	CcSEcCtD
Gefitinib—Body temperature increased—Cyclosporine—rheumatoid arthritis	7.4e-05	0.000777	CcSEcCtD
Gefitinib—CHEK2—Levonorgestrel—Hydrocortisone—rheumatoid arthritis	7.36e-05	0.0326	CbGdCrCtD
Gefitinib—Haemoglobin—Methotrexate—rheumatoid arthritis	7.32e-05	0.000768	CcSEcCtD
Gefitinib—Hypotension—Methylprednisolone—rheumatoid arthritis	7.3e-05	0.000767	CcSEcCtD
Gefitinib—Pain—Prednisolone—rheumatoid arthritis	7.28e-05	0.000765	CcSEcCtD
Gefitinib—Haemorrhage—Methotrexate—rheumatoid arthritis	7.28e-05	0.000764	CcSEcCtD
Gefitinib—Hepatitis—Methotrexate—rheumatoid arthritis	7.28e-05	0.000764	CcSEcCtD
Gefitinib—Decreased appetite—Hydrocortisone—rheumatoid arthritis	7.23e-05	0.000759	CcSEcCtD
Gefitinib—Nausea—Leflunomide—rheumatoid arthritis	7.2e-05	0.000756	CcSEcCtD
Gefitinib—Urinary tract disorder—Methotrexate—rheumatoid arthritis	7.19e-05	0.000755	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	7.18e-05	0.000754	CcSEcCtD
Gefitinib—Fatigue—Hydrocortisone—rheumatoid arthritis	7.17e-05	0.000753	CcSEcCtD
Gefitinib—Urethral disorder—Methotrexate—rheumatoid arthritis	7.14e-05	0.000749	CcSEcCtD
Gefitinib—Pain—Hydrocortisone—rheumatoid arthritis	7.11e-05	0.000747	CcSEcCtD
Gefitinib—Infection—Dexamethasone—rheumatoid arthritis	7.06e-05	0.000741	CcSEcCtD
Gefitinib—Infection—Betamethasone—rheumatoid arthritis	7.06e-05	0.000741	CcSEcCtD
Gefitinib—Anaemia—Prednisone—rheumatoid arthritis	7.01e-05	0.000736	CcSEcCtD
Gefitinib—Shock—Dexamethasone—rheumatoid arthritis	6.99e-05	0.000734	CcSEcCtD
Gefitinib—Shock—Betamethasone—rheumatoid arthritis	6.99e-05	0.000734	CcSEcCtD
Gefitinib—Dyspnoea—Triamcinolone—rheumatoid arthritis	6.98e-05	0.000733	CcSEcCtD
Gefitinib—Nervous system disorder—Dexamethasone—rheumatoid arthritis	6.97e-05	0.000732	CcSEcCtD
Gefitinib—Nervous system disorder—Betamethasone—rheumatoid arthritis	6.97e-05	0.000732	CcSEcCtD
Gefitinib—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	6.96e-05	0.000731	CcSEcCtD
Gefitinib—Thrombocytopenia—Betamethasone—rheumatoid arthritis	6.96e-05	0.000731	CcSEcCtD
Gefitinib—Angioedema—Prednisone—rheumatoid arthritis	6.93e-05	0.000727	CcSEcCtD
Gefitinib—Hypersensitivity—Cyclosporine—rheumatoid arthritis	6.9e-05	0.000724	CcSEcCtD
Gefitinib—Erythema multiforme—Methotrexate—rheumatoid arthritis	6.88e-05	0.000723	CcSEcCtD
Gefitinib—Malaise—Prednisone—rheumatoid arthritis	6.84e-05	0.000718	CcSEcCtD
Gefitinib—Eye disorder—Methotrexate—rheumatoid arthritis	6.8e-05	0.000714	CcSEcCtD
Gefitinib—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	6.8e-05	0.000714	CcSEcCtD
Gefitinib—Anorexia—Dexamethasone—rheumatoid arthritis	6.77e-05	0.000711	CcSEcCtD
Gefitinib—Anorexia—Betamethasone—rheumatoid arthritis	6.77e-05	0.000711	CcSEcCtD
Gefitinib—Urticaria—Prednisolone—rheumatoid arthritis	6.77e-05	0.00071	CcSEcCtD
Gefitinib—Cardiac disorder—Methotrexate—rheumatoid arthritis	6.76e-05	0.000709	CcSEcCtD
Gefitinib—Fatigue—Triamcinolone—rheumatoid arthritis	6.75e-05	0.000709	CcSEcCtD
Gefitinib—Fatigue—Methylprednisolone—rheumatoid arthritis	6.74e-05	0.000707	CcSEcCtD
Gefitinib—Asthenia—Cyclosporine—rheumatoid arthritis	6.71e-05	0.000705	CcSEcCtD
Gefitinib—Pain—Triamcinolone—rheumatoid arthritis	6.7e-05	0.000703	CcSEcCtD
Gefitinib—Hypotension—Dexamethasone—rheumatoid arthritis	6.64e-05	0.000697	CcSEcCtD
Gefitinib—Hypotension—Betamethasone—rheumatoid arthritis	6.64e-05	0.000697	CcSEcCtD
Gefitinib—Pruritus—Cyclosporine—rheumatoid arthritis	6.62e-05	0.000695	CcSEcCtD
Gefitinib—Urticaria—Hydrocortisone—rheumatoid arthritis	6.61e-05	0.000694	CcSEcCtD
Gefitinib—Angiopathy—Methotrexate—rheumatoid arthritis	6.6e-05	0.000693	CcSEcCtD
Gefitinib—Abdominal pain—Hydrocortisone—rheumatoid arthritis	6.57e-05	0.00069	CcSEcCtD
Gefitinib—Body temperature increased—Hydrocortisone—rheumatoid arthritis	6.57e-05	0.00069	CcSEcCtD
Gefitinib—Mediastinal disorder—Methotrexate—rheumatoid arthritis	6.56e-05	0.000689	CcSEcCtD
Gefitinib—Alopecia—Methotrexate—rheumatoid arthritis	6.43e-05	0.000675	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	6.41e-05	0.000673	CcSEcCtD
Gefitinib—Diarrhoea—Cyclosporine—rheumatoid arthritis	6.4e-05	0.000672	CcSEcCtD
Gefitinib—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	6.39e-05	0.000671	CcSEcCtD
Gefitinib—Malnutrition—Methotrexate—rheumatoid arthritis	6.34e-05	0.000665	CcSEcCtD
Gefitinib—Hypersensitivity—Prednisolone—rheumatoid arthritis	6.27e-05	0.000659	CcSEcCtD
Gefitinib—Urticaria—Triamcinolone—rheumatoid arthritis	6.22e-05	0.000653	CcSEcCtD
Gefitinib—Urticaria—Methylprednisolone—rheumatoid arthritis	6.21e-05	0.000652	CcSEcCtD
Gefitinib—Body temperature increased—Triamcinolone—rheumatoid arthritis	6.19e-05	0.00065	CcSEcCtD
Gefitinib—Abdominal pain—Methylprednisolone—rheumatoid arthritis	6.18e-05	0.000649	CcSEcCtD
Gefitinib—Decreased appetite—Dexamethasone—rheumatoid arthritis	6.18e-05	0.000649	CcSEcCtD
Gefitinib—Decreased appetite—Betamethasone—rheumatoid arthritis	6.18e-05	0.000649	CcSEcCtD
Gefitinib—Infection—Prednisone—rheumatoid arthritis	6.15e-05	0.000646	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	6.13e-05	0.000644	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	6.13e-05	0.000644	CcSEcCtD
Gefitinib—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	6.13e-05	0.000643	CcSEcCtD
Gefitinib—Fatigue—Dexamethasone—rheumatoid arthritis	6.13e-05	0.000643	CcSEcCtD
Gefitinib—Fatigue—Betamethasone—rheumatoid arthritis	6.13e-05	0.000643	CcSEcCtD
Gefitinib—Shock—Prednisone—rheumatoid arthritis	6.09e-05	0.000639	CcSEcCtD
Gefitinib—Pain—Dexamethasone—rheumatoid arthritis	6.08e-05	0.000638	CcSEcCtD
Gefitinib—Pain—Betamethasone—rheumatoid arthritis	6.08e-05	0.000638	CcSEcCtD
Gefitinib—Nervous system disorder—Prednisone—rheumatoid arthritis	6.07e-05	0.000637	CcSEcCtD
Gefitinib—Skin disorder—Prednisone—rheumatoid arthritis	6.01e-05	0.000631	CcSEcCtD
Gefitinib—Asthenia—Hydrocortisone—rheumatoid arthritis	5.97e-05	0.000627	CcSEcCtD
Gefitinib—Vomiting—Cyclosporine—rheumatoid arthritis	5.95e-05	0.000625	CcSEcCtD
Gefitinib—Rash—Cyclosporine—rheumatoid arthritis	5.9e-05	0.00062	CcSEcCtD
Gefitinib—Anorexia—Prednisone—rheumatoid arthritis	5.9e-05	0.000619	CcSEcCtD
Gefitinib—Dermatitis—Cyclosporine—rheumatoid arthritis	5.9e-05	0.000619	CcSEcCtD
Gefitinib—Pruritus—Hydrocortisone—rheumatoid arthritis	5.88e-05	0.000618	CcSEcCtD
Gefitinib—Erlotinib—ALB—rheumatoid arthritis	5.86e-05	0.0106	CrCbGaD
Gefitinib—Anaemia—Methotrexate—rheumatoid arthritis	5.86e-05	0.000615	CcSEcCtD
Gefitinib—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	5.81e-05	0.00061	CcSEcCtD
Gefitinib—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	5.81e-05	0.00061	CcSEcCtD
Gefitinib—Hypersensitivity—Triamcinolone—rheumatoid arthritis	5.77e-05	0.000606	CcSEcCtD
Gefitinib—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	5.76e-05	0.000604	CcSEcCtD
Gefitinib—Malaise—Methotrexate—rheumatoid arthritis	5.71e-05	0.0006	CcSEcCtD
Gefitinib—Diarrhoea—Hydrocortisone—rheumatoid arthritis	5.69e-05	0.000598	CcSEcCtD
Gefitinib—Urticaria—Dexamethasone—rheumatoid arthritis	5.65e-05	0.000593	CcSEcCtD
Gefitinib—Urticaria—Betamethasone—rheumatoid arthritis	5.65e-05	0.000593	CcSEcCtD
Gefitinib—Asthenia—Triamcinolone—rheumatoid arthritis	5.62e-05	0.00059	CcSEcCtD
Gefitinib—Body temperature increased—Betamethasone—rheumatoid arthritis	5.62e-05	0.00059	CcSEcCtD
Gefitinib—Body temperature increased—Dexamethasone—rheumatoid arthritis	5.62e-05	0.00059	CcSEcCtD
Gefitinib—Abdominal pain—Betamethasone—rheumatoid arthritis	5.62e-05	0.00059	CcSEcCtD
Gefitinib—Abdominal pain—Dexamethasone—rheumatoid arthritis	5.62e-05	0.00059	CcSEcCtD
Gefitinib—Asthenia—Methylprednisolone—rheumatoid arthritis	5.61e-05	0.000589	CcSEcCtD
Gefitinib—Nausea—Cyclosporine—rheumatoid arthritis	5.56e-05	0.000584	CcSEcCtD
Gefitinib—Pruritus—Triamcinolone—rheumatoid arthritis	5.54e-05	0.000582	CcSEcCtD
Gefitinib—Cough—Methotrexate—rheumatoid arthritis	5.53e-05	0.000581	CcSEcCtD
Gefitinib—Pruritus—Methylprednisolone—rheumatoid arthritis	5.53e-05	0.00058	CcSEcCtD
Gefitinib—Decreased appetite—Prednisone—rheumatoid arthritis	5.38e-05	0.000565	CcSEcCtD
Gefitinib—Rash—Prednisolone—rheumatoid arthritis	5.37e-05	0.000564	CcSEcCtD
Gefitinib—Dermatitis—Prednisolone—rheumatoid arthritis	5.36e-05	0.000563	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	5.36e-05	0.000563	CcSEcCtD
Gefitinib—Diarrhoea—Methylprednisolone—rheumatoid arthritis	5.35e-05	0.000561	CcSEcCtD
Gefitinib—Fatigue—Prednisone—rheumatoid arthritis	5.34e-05	0.00056	CcSEcCtD
Gefitinib—Constipation—Prednisone—rheumatoid arthritis	5.29e-05	0.000556	CcSEcCtD
Gefitinib—Vomiting—Hydrocortisone—rheumatoid arthritis	5.29e-05	0.000555	CcSEcCtD
Gefitinib—Rash—Hydrocortisone—rheumatoid arthritis	5.24e-05	0.000551	CcSEcCtD
Gefitinib—Dermatitis—Hydrocortisone—rheumatoid arthritis	5.24e-05	0.00055	CcSEcCtD
Gefitinib—Infection—Methotrexate—rheumatoid arthritis	5.14e-05	0.000539	CcSEcCtD
Gefitinib—Asthenia—Betamethasone—rheumatoid arthritis	5.1e-05	0.000535	CcSEcCtD
Gefitinib—Asthenia—Dexamethasone—rheumatoid arthritis	5.1e-05	0.000535	CcSEcCtD
Gefitinib—Nervous system disorder—Methotrexate—rheumatoid arthritis	5.07e-05	0.000533	CcSEcCtD
Gefitinib—Thrombocytopenia—Methotrexate—rheumatoid arthritis	5.06e-05	0.000532	CcSEcCtD
Gefitinib—Gastrointestinal pain—Prednisone—rheumatoid arthritis	5.06e-05	0.000531	CcSEcCtD
Gefitinib—Nausea—Prednisolone—rheumatoid arthritis	5.06e-05	0.000531	CcSEcCtD
Gefitinib—Pruritus—Betamethasone—rheumatoid arthritis	5.03e-05	0.000528	CcSEcCtD
Gefitinib—Pruritus—Dexamethasone—rheumatoid arthritis	5.03e-05	0.000528	CcSEcCtD
Gefitinib—Skin disorder—Methotrexate—rheumatoid arthritis	5.02e-05	0.000527	CcSEcCtD
Gefitinib—Vomiting—Triamcinolone—rheumatoid arthritis	4.98e-05	0.000523	CcSEcCtD
Gefitinib—Vomiting—Methylprednisolone—rheumatoid arthritis	4.97e-05	0.000522	CcSEcCtD
Gefitinib—Nausea—Hydrocortisone—rheumatoid arthritis	4.94e-05	0.000519	CcSEcCtD
Gefitinib—Rash—Triamcinolone—rheumatoid arthritis	4.94e-05	0.000518	CcSEcCtD
Gefitinib—Dermatitis—Triamcinolone—rheumatoid arthritis	4.93e-05	0.000518	CcSEcCtD
Gefitinib—Anorexia—Methotrexate—rheumatoid arthritis	4.93e-05	0.000518	CcSEcCtD
Gefitinib—Rash—Methylprednisolone—rheumatoid arthritis	4.93e-05	0.000517	CcSEcCtD
Gefitinib—Dermatitis—Methylprednisolone—rheumatoid arthritis	4.92e-05	0.000517	CcSEcCtD
Gefitinib—Urticaria—Prednisone—rheumatoid arthritis	4.92e-05	0.000516	CcSEcCtD
Gefitinib—Abdominal pain—Prednisone—rheumatoid arthritis	4.89e-05	0.000514	CcSEcCtD
Gefitinib—Body temperature increased—Prednisone—rheumatoid arthritis	4.89e-05	0.000514	CcSEcCtD
Gefitinib—Diarrhoea—Dexamethasone—rheumatoid arthritis	4.86e-05	0.000511	CcSEcCtD
Gefitinib—Diarrhoea—Betamethasone—rheumatoid arthritis	4.86e-05	0.000511	CcSEcCtD
Gefitinib—Hypotension—Methotrexate—rheumatoid arthritis	4.83e-05	0.000507	CcSEcCtD
Gefitinib—Nausea—Triamcinolone—rheumatoid arthritis	4.65e-05	0.000488	CcSEcCtD
Gefitinib—Nausea—Methylprednisolone—rheumatoid arthritis	4.64e-05	0.000487	CcSEcCtD
Gefitinib—Dyspnoea—Methotrexate—rheumatoid arthritis	4.61e-05	0.000484	CcSEcCtD
Gefitinib—Hypersensitivity—Prednisone—rheumatoid arthritis	4.56e-05	0.000479	CcSEcCtD
Gefitinib—Vomiting—Betamethasone—rheumatoid arthritis	4.52e-05	0.000474	CcSEcCtD
Gefitinib—Vomiting—Dexamethasone—rheumatoid arthritis	4.52e-05	0.000474	CcSEcCtD
Gefitinib—Decreased appetite—Methotrexate—rheumatoid arthritis	4.5e-05	0.000472	CcSEcCtD
Gefitinib—Rash—Betamethasone—rheumatoid arthritis	4.48e-05	0.00047	CcSEcCtD
Gefitinib—Rash—Dexamethasone—rheumatoid arthritis	4.48e-05	0.00047	CcSEcCtD
Gefitinib—Dermatitis—Dexamethasone—rheumatoid arthritis	4.48e-05	0.00047	CcSEcCtD
Gefitinib—Dermatitis—Betamethasone—rheumatoid arthritis	4.48e-05	0.00047	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	4.47e-05	0.000469	CcSEcCtD
Gefitinib—Fatigue—Methotrexate—rheumatoid arthritis	4.46e-05	0.000468	CcSEcCtD
Gefitinib—Asthenia—Prednisone—rheumatoid arthritis	4.44e-05	0.000466	CcSEcCtD
Gefitinib—Pain—Methotrexate—rheumatoid arthritis	4.42e-05	0.000464	CcSEcCtD
Gefitinib—Pruritus—Prednisone—rheumatoid arthritis	4.38e-05	0.00046	CcSEcCtD
Gefitinib—Diarrhoea—Prednisone—rheumatoid arthritis	4.23e-05	0.000445	CcSEcCtD
Gefitinib—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	4.23e-05	0.000444	CcSEcCtD
Gefitinib—Nausea—Betamethasone—rheumatoid arthritis	4.22e-05	0.000443	CcSEcCtD
Gefitinib—Nausea—Dexamethasone—rheumatoid arthritis	4.22e-05	0.000443	CcSEcCtD
Gefitinib—Urticaria—Methotrexate—rheumatoid arthritis	4.11e-05	0.000431	CcSEcCtD
Gefitinib—Body temperature increased—Methotrexate—rheumatoid arthritis	4.09e-05	0.000429	CcSEcCtD
Gefitinib—Abdominal pain—Methotrexate—rheumatoid arthritis	4.09e-05	0.000429	CcSEcCtD
Gefitinib—Vomiting—Prednisone—rheumatoid arthritis	3.93e-05	0.000413	CcSEcCtD
Gefitinib—Rash—Prednisone—rheumatoid arthritis	3.9e-05	0.00041	CcSEcCtD
Gefitinib—Dermatitis—Prednisone—rheumatoid arthritis	3.9e-05	0.000409	CcSEcCtD
Gefitinib—Vandetanib—ALB—rheumatoid arthritis	3.86e-05	0.00699	CrCbGaD
Gefitinib—Hypersensitivity—Methotrexate—rheumatoid arthritis	3.81e-05	0.0004	CcSEcCtD
Gefitinib—Asthenia—Methotrexate—rheumatoid arthritis	3.71e-05	0.00039	CcSEcCtD
Gefitinib—Nausea—Prednisone—rheumatoid arthritis	3.68e-05	0.000386	CcSEcCtD
Gefitinib—Pruritus—Methotrexate—rheumatoid arthritis	3.66e-05	0.000384	CcSEcCtD
Gefitinib—Diarrhoea—Methotrexate—rheumatoid arthritis	3.54e-05	0.000372	CcSEcCtD
Gefitinib—Vomiting—Methotrexate—rheumatoid arthritis	3.29e-05	0.000345	CcSEcCtD
Gefitinib—Rash—Methotrexate—rheumatoid arthritis	3.26e-05	0.000342	CcSEcCtD
Gefitinib—Dermatitis—Methotrexate—rheumatoid arthritis	3.26e-05	0.000342	CcSEcCtD
Gefitinib—Nausea—Methotrexate—rheumatoid arthritis	3.07e-05	0.000323	CcSEcCtD
Gefitinib—IRAK1—Immune System—CD4—rheumatoid arthritis	3.95e-06	3.83e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—IL6ST—rheumatoid arthritis	3.94e-06	3.82e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—ADRBK1—rheumatoid arthritis	3.93e-06	3.81e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—NOS2—rheumatoid arthritis	3.92e-06	3.8e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CRP—rheumatoid arthritis	3.91e-06	3.79e-05	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—NFKB1—rheumatoid arthritis	3.91e-06	3.79e-05	CbGpPWpGaD
Gefitinib—EGFR—Axon guidance—IL6—rheumatoid arthritis	3.9e-06	3.78e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—CCR5—rheumatoid arthritis	3.89e-06	3.77e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—CXCL8—rheumatoid arthritis	3.88e-06	3.76e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CCL2—rheumatoid arthritis	3.88e-06	3.76e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—IL6R—rheumatoid arthritis	3.87e-06	3.75e-05	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—MAPK8—rheumatoid arthritis	3.84e-06	3.73e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—POMC—rheumatoid arthritis	3.82e-06	3.7e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—MTHFR—rheumatoid arthritis	3.8e-06	3.68e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—HLA-A—rheumatoid arthritis	3.79e-06	3.67e-05	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—NFKB1—rheumatoid arthritis	3.76e-06	3.64e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—TLR4—rheumatoid arthritis	3.75e-06	3.64e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—HLA-DRB1—rheumatoid arthritis	3.75e-06	3.63e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—ALOX5—rheumatoid arthritis	3.74e-06	3.63e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CCL2—rheumatoid arthritis	3.74e-06	3.62e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—B3GNT2—rheumatoid arthritis	3.73e-06	3.61e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ACP5—rheumatoid arthritis	3.73e-06	3.61e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—IL6R—rheumatoid arthritis	3.73e-06	3.61e-05	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—TGFB1—rheumatoid arthritis	3.72e-06	3.6e-05	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	3.72e-06	3.6e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—IL2—rheumatoid arthritis	3.71e-06	3.59e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—RASGRP1—rheumatoid arthritis	3.7e-06	3.59e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—LEP—rheumatoid arthritis	3.7e-06	3.59e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—B3GNT2—rheumatoid arthritis	3.7e-06	3.58e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ACP5—rheumatoid arthritis	3.7e-06	3.58e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—SYK—rheumatoid arthritis	3.69e-06	3.58e-05	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—TGFB1—rheumatoid arthritis	3.69e-06	3.58e-05	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—IL6—rheumatoid arthritis	3.67e-06	3.56e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IL1B—rheumatoid arthritis	3.65e-06	3.54e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—BGN—rheumatoid arthritis	3.65e-06	3.54e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PLD4—rheumatoid arthritis	3.64e-06	3.53e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IL2—rheumatoid arthritis	3.64e-06	3.53e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—PRKCQ—rheumatoid arthritis	3.62e-06	3.51e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	3.61e-06	3.5e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—POMC—rheumatoid arthritis	3.6e-06	3.49e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL6ST—rheumatoid arthritis	3.6e-06	3.49e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—ICAM1—rheumatoid arthritis	3.6e-06	3.49e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—BGN—rheumatoid arthritis	3.56e-06	3.45e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—STAT1—rheumatoid arthritis	3.56e-06	3.45e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—CAT—rheumatoid arthritis	3.56e-06	3.45e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—ENO1—rheumatoid arthritis	3.54e-06	3.43e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—CCL2—rheumatoid arthritis	3.52e-06	3.42e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—TYK2—rheumatoid arthritis	3.52e-06	3.41e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ACAN—rheumatoid arthritis	3.52e-06	3.41e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—IL6R—rheumatoid arthritis	3.51e-06	3.41e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CXCL10—rheumatoid arthritis	3.51e-06	3.4e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—MMP9—rheumatoid arthritis	3.51e-06	3.4e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—FN1—rheumatoid arthritis	3.49e-06	3.39e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—IL6ST—rheumatoid arthritis	3.48e-06	3.37e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—NFKB1—rheumatoid arthritis	3.47e-06	3.37e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CD80—rheumatoid arthritis	3.46e-06	3.36e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—NOS3—rheumatoid arthritis	3.46e-06	3.35e-05	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—TNF—rheumatoid arthritis	3.44e-06	3.34e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—MAPK8—rheumatoid arthritis	3.41e-06	3.31e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—NFKB1—rheumatoid arthritis	3.41e-06	3.3e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—TYK2—rheumatoid arthritis	3.4e-06	3.29e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ALOX5—rheumatoid arthritis	3.36e-06	3.26e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—BGN—rheumatoid arthritis	3.36e-06	3.25e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—MAPK8—rheumatoid arthritis	3.35e-06	3.25e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CD80—rheumatoid arthritis	3.35e-06	3.25e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—ENO1—rheumatoid arthritis	3.35e-06	3.24e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—NOS3—rheumatoid arthritis	3.33e-06	3.23e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—BGN—rheumatoid arthritis	3.33e-06	3.23e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—IL6ST—rheumatoid arthritis	3.32e-06	3.22e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—SLC25A12—rheumatoid arthritis	3.31e-06	3.21e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—NOS2—rheumatoid arthritis	3.3e-06	3.19e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	3.29e-06	3.19e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	3.29e-06	3.19e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ALOX5—rheumatoid arthritis	3.28e-06	3.18e-05	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	3.28e-06	3.18e-05	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—IL6—rheumatoid arthritis	3.22e-06	3.12e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PTGES—rheumatoid arthritis	3.22e-06	3.12e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GC—rheumatoid arthritis	3.22e-06	3.12e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL6R—rheumatoid arthritis	3.21e-06	3.11e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—MMP3—rheumatoid arthritis	3.2e-06	3.1e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—TYK2—rheumatoid arthritis	3.2e-06	3.1e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—CD80—rheumatoid arthritis	3.2e-06	3.1e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—POMC—rheumatoid arthritis	3.18e-06	3.08e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—NOS3—rheumatoid arthritis	3.15e-06	3.06e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—VEGFA—rheumatoid arthritis	3.15e-06	3.05e-05	CbGpPWpGaD
Gefitinib—ERBB3—Disease—TGFB1—rheumatoid arthritis	3.15e-06	3.05e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CCL2—rheumatoid arthritis	3.11e-06	3.02e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—IL6—rheumatoid arthritis	3.11e-06	3.02e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—IL6R—rheumatoid arthritis	3.1e-06	3.01e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ALOX5—rheumatoid arthritis	3.09e-06	2.99e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—PTK2—rheumatoid arthritis	3.08e-06	2.99e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CXCL8—rheumatoid arthritis	3.07e-06	2.97e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ALOX5—rheumatoid arthritis	3.06e-06	2.97e-05	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—TP53—rheumatoid arthritis	3.06e-06	2.97e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—ENO1—rheumatoid arthritis	3.05e-06	2.96e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CCL5—rheumatoid arthritis	3.02e-06	2.93e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PLB1—rheumatoid arthritis	2.99e-06	2.9e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CSF2—rheumatoid arthritis	2.98e-06	2.88e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—MTHFR—rheumatoid arthritis	2.97e-06	2.88e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—IL6R—rheumatoid arthritis	2.96e-06	2.87e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CXCL8—rheumatoid arthritis	2.96e-06	2.87e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	2.95e-06	2.86e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—IL2—rheumatoid arthritis	2.93e-06	2.84e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—TYK2—rheumatoid arthritis	2.92e-06	2.83e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—TGFB1—rheumatoid arthritis	2.89e-06	2.8e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	2.88e-06	2.79e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TYK2—rheumatoid arthritis	2.83e-06	2.74e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—IL2—rheumatoid arthritis	2.82e-06	2.74e-05	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—IL6—rheumatoid arthritis	2.8e-06	2.72e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—SPP1—rheumatoid arthritis	2.8e-06	2.71e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—CXCL8—rheumatoid arthritis	2.79e-06	2.7e-05	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—IL6—rheumatoid arthritis	2.78e-06	2.69e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—NOS3—rheumatoid arthritis	2.77e-06	2.69e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—MMP9—rheumatoid arthritis	2.77e-06	2.69e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—NFKB1—rheumatoid arthritis	2.74e-06	2.66e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ENO1—rheumatoid arthritis	2.74e-06	2.65e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IFNG—rheumatoid arthritis	2.74e-06	2.65e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CCR5—rheumatoid arthritis	2.72e-06	2.64e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—TYK2—rheumatoid arthritis	2.7e-06	2.62e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—MAPK8—rheumatoid arthritis	2.7e-06	2.61e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	2.69e-06	2.61e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	2.69e-06	2.61e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IL2RA—rheumatoid arthritis	2.68e-06	2.6e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—MMP9—rheumatoid arthritis	2.67e-06	2.59e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ENO1—rheumatoid arthritis	2.67e-06	2.59e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—IL2—rheumatoid arthritis	2.67e-06	2.59e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—IL2—rheumatoid arthritis	2.66e-06	2.58e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—C3—rheumatoid arthritis	2.66e-06	2.58e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—NOS3—rheumatoid arthritis	2.65e-06	2.57e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—NFKB1—rheumatoid arthritis	2.65e-06	2.56e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CD4—rheumatoid arthritis	2.64e-06	2.56e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	2.62e-06	2.54e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—MED1—rheumatoid arthritis	2.62e-06	2.54e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—MAPK8—rheumatoid arthritis	2.6e-06	2.52e-05	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IL6—rheumatoid arthritis	2.57e-06	2.49e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—CAT—rheumatoid arthritis	2.55e-06	2.47e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ENO1—rheumatoid arthritis	2.52e-06	2.44e-05	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	2.5e-06	2.42e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ENO1—rheumatoid arthritis	2.5e-06	2.42e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—VEGFA—rheumatoid arthritis	2.49e-06	2.41e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—LEP—rheumatoid arthritis	2.48e-06	2.4e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CXCL8—rheumatoid arthritis	2.46e-06	2.39e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	2.46e-06	2.38e-05	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—IL6—rheumatoid arthritis	2.45e-06	2.38e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL1B—rheumatoid arthritis	2.44e-06	2.37e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—CD4—rheumatoid arthritis	2.44e-06	2.37e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	2.44e-06	2.36e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	2.44e-06	2.36e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL2—rheumatoid arthritis	2.43e-06	2.36e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—PTGS2—rheumatoid arthritis	2.42e-06	2.35e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—CAT—rheumatoid arthritis	2.41e-06	2.33e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—VEGFA—rheumatoid arthritis	2.4e-06	2.33e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—TP53—rheumatoid arthritis	2.38e-06	2.31e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—POMC—rheumatoid arthritis	2.38e-06	2.3e-05	CbGpPWpGaD
Gefitinib—ERBB3—Disease—IL6—rheumatoid arthritis	2.37e-06	2.3e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	2.36e-06	2.28e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—IL2—rheumatoid arthritis	2.35e-06	2.28e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—FN1—rheumatoid arthritis	2.34e-06	2.26e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IL6ST—rheumatoid arthritis	2.33e-06	2.25e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—TGFB1—rheumatoid arthritis	2.29e-06	2.22e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—NFKB1—rheumatoid arthritis	2.28e-06	2.21e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—VEGFA—rheumatoid arthritis	2.27e-06	2.2e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—MAPK8—rheumatoid arthritis	2.24e-06	2.17e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CD80—rheumatoid arthritis	2.24e-06	2.17e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—MMP9—rheumatoid arthritis	2.23e-06	2.16e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—TGFB1—rheumatoid arthritis	2.2e-06	2.14e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—NFKB1—rheumatoid arthritis	2.2e-06	2.13e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—CAT—rheumatoid arthritis	2.2e-06	2.13e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—BGN—rheumatoid arthritis	2.19e-06	2.13e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—IL6—rheumatoid arthritis	2.18e-06	2.11e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—ALB—rheumatoid arthritis	2.17e-06	2.1e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—MAPK8—rheumatoid arthritis	2.16e-06	2.1e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	2.15e-06	2.08e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IL6—rheumatoid arthritis	2.14e-06	2.07e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—MTHFR—rheumatoid arthritis	2.13e-06	2.06e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—POMC—rheumatoid arthritis	2.13e-06	2.06e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—TGFB1—rheumatoid arthritis	2.08e-06	2.02e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CCL2—rheumatoid arthritis	2.08e-06	2.02e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IL6R—rheumatoid arthritis	2.08e-06	2.01e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—NOS3—rheumatoid arthritis	2.07e-06	2.01e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	2.02e-06	1.96e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—MTHFR—rheumatoid arthritis	2.01e-06	1.95e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—VEGFA—rheumatoid arthritis	2e-06	1.94e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—CAT—rheumatoid arthritis	1.97e-06	1.91e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—CAT—rheumatoid arthritis	1.92e-06	1.86e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—PTGS2—rheumatoid arthritis	1.89e-06	1.84e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TYK2—rheumatoid arthritis	1.89e-06	1.83e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—TP53—rheumatoid arthritis	1.88e-06	1.82e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—NOS3—rheumatoid arthritis	1.86e-06	1.8e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TGFB1—rheumatoid arthritis	1.83e-06	1.78e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—MTHFR—rheumatoid arthritis	1.83e-06	1.78e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—TP53—rheumatoid arthritis	1.81e-06	1.76e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—CAT—rheumatoid arthritis	1.81e-06	1.76e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—CAT—rheumatoid arthritis	1.8e-06	1.74e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—TGFB1—rheumatoid arthritis	1.75e-06	1.7e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—IL6—rheumatoid arthritis	1.72e-06	1.67e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—TP53—rheumatoid arthritis	1.72e-06	1.66e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—POMC—rheumatoid arthritis	1.7e-06	1.65e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—IL6—rheumatoid arthritis	1.66e-06	1.61e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	1.65e-06	1.6e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CXCL8—rheumatoid arthritis	1.65e-06	1.6e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—MTHFR—rheumatoid arthritis	1.65e-06	1.59e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—POMC—rheumatoid arthritis	1.61e-06	1.56e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—MTHFR—rheumatoid arthritis	1.61e-06	1.56e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IL2—rheumatoid arthritis	1.57e-06	1.52e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—IL6—rheumatoid arthritis	1.56e-06	1.52e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—ALB—rheumatoid arthritis	1.55e-06	1.5e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—MTHFR—rheumatoid arthritis	1.51e-06	1.47e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TP53—rheumatoid arthritis	1.51e-06	1.46e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—MTHFR—rheumatoid arthritis	1.5e-06	1.45e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—MMP9—rheumatoid arthritis	1.49e-06	1.44e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—NOS3—rheumatoid arthritis	1.48e-06	1.44e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—NFKB1—rheumatoid arthritis	1.47e-06	1.43e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—ALB—rheumatoid arthritis	1.47e-06	1.42e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—POMC—rheumatoid arthritis	1.47e-06	1.42e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—MAPK8—rheumatoid arthritis	1.45e-06	1.4e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL6—rheumatoid arthritis	1.43e-06	1.39e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—NOS3—rheumatoid arthritis	1.4e-06	1.36e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—IL6—rheumatoid arthritis	1.38e-06	1.34e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PTGS2—rheumatoid arthritis	1.36e-06	1.32e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—VEGFA—rheumatoid arthritis	1.34e-06	1.3e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—IL6—rheumatoid arthritis	1.32e-06	1.28e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—POMC—rheumatoid arthritis	1.32e-06	1.28e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—POMC—rheumatoid arthritis	1.28e-06	1.24e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PTGS2—rheumatoid arthritis	1.28e-06	1.24e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—NOS3—rheumatoid arthritis	1.28e-06	1.24e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TGFB1—rheumatoid arthritis	1.23e-06	1.19e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—POMC—rheumatoid arthritis	1.21e-06	1.17e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—POMC—rheumatoid arthritis	1.2e-06	1.16e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ALB—rheumatoid arthritis	1.2e-06	1.16e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CAT—rheumatoid arthritis	1.19e-06	1.15e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ALB—rheumatoid arthritis	1.17e-06	1.13e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PTGS2—rheumatoid arthritis	1.17e-06	1.13e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—NOS3—rheumatoid arthritis	1.15e-06	1.11e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—NOS3—rheumatoid arthritis	1.12e-06	1.09e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ALB—rheumatoid arthritis	1.1e-06	1.07e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ALB—rheumatoid arthritis	1.09e-06	1.06e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—NOS3—rheumatoid arthritis	1.06e-06	1.02e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PTGS2—rheumatoid arthritis	1.05e-06	1.02e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—NOS3—rheumatoid arthritis	1.05e-06	1.01e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PTGS2—rheumatoid arthritis	1.02e-06	9.93e-06	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TP53—rheumatoid arthritis	1.01e-06	9.79e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	9.89e-07	9.59e-06	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PTGS2—rheumatoid arthritis	9.65e-07	9.36e-06	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PTGS2—rheumatoid arthritis	9.57e-07	9.27e-06	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IL6—rheumatoid arthritis	9.24e-07	8.96e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—POMC—rheumatoid arthritis	7.91e-07	7.67e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ALB—rheumatoid arthritis	7.21e-07	6.99e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	6.9e-07	6.69e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	6.31e-07	6.12e-06	CbGpPWpGaD
